title: Increased PGE2 production mediates the in vitro inhibitory effect of the human immunodeficiency virus P24 immunosuppressive heptapeptide Ch7.
abstract: Previous work from our laboratory demonstrated that a synthetic heptapeptide (Ch7), corresponding to a conserved sequence of human immunodeficiency virus (HIV) core protein p24 (amino acids 232-238), was able to specifically abrogate antigen-induced responses in cultures of normal human peripheral blood lymphocytes (PBL). Addition of recombinant human interferon-gamma (IFN-gamma) to Ch7-suppressed cultures restored the capacity to mount an antigen-specific antibody response, suggesting that a cytokine imbalance may be at the basis of the Ch7 immunosuppressive activity. In the present paper we show that the Ch7-dependent in vitro immunosuppression was accompanied by a significant up-regulation of prostaglandin E2 (PGE2) production and induction of interleukin-10 (IL-10)-secreting cells. In the presence of the PGE2 inhibitor indomethacin, IL-10 up-regulation was prevented and the induction of a specific antibody response was partially restored. PGE2 is indeed an important regulator of immune responses with the ability to differentially affect cytokine production. Thus, our results demonstrate that the Ch7 immunosuppressive epitope may primarily act by up-regulating PGE2 production and, through this mediator, by causing a cytokine dysregulation, finally responsible for immune response suppression.
authors.affiliation: Department of Immunology, Istituto Superiore di Sanità, Rome, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Giacomini
authors.forename: L
authors.initials: L
authors.lastname: Giordani
authors.forename: F
authors.initials: F
authors.lastname: di Modugno
authors.forename: A
authors.initials: A
authors.lastname: Chersi
authors.forename: A L
authors.initials: AL
authors.lastname: Luzzati
mesh_terms: D000917:Antibody Formation / Q000187:drug effects; D000921:Antibody-Producing Cells / Q000737:chemistry; D015232:Dinoprostone / Q000096:biosynthesis* / Q000502:physiology*; D016655:HIV Core Protein p24 / Q000187:drug effects* / Q000494:pharmacology; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D007213:Indomethacin / Q000494:pharmacology; D016753:Interleukin-10 / Q000096:biosynthesis / Q000502:physiology; D009842:Oligopeptides / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D016655:HIV Core Protein p24; D007166:Immunosuppressive Agents; D009842:Oligopeptides; D016753:Interleukin-10; D015232:Dinoprostone; D007213:Indomethacin